4//SEC Filing
Straughen Michael 4
Accession 0000950170-24-040347
CIK 0001958086other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:10 PM ET
Size
10.1 KB
Accession
0000950170-24-040347
Insider Transaction Report
Form 4
Straughen Michael
Director
Transactions
- Tax Payment
Common Stock
2024-04-01$17.13/sh−3,017$51,681→ 19,869 total - Exercise/Conversion
Common Stock
2024-04-01+6,419→ 22,886 total - Award
Restricted Shares
2024-04-01+9,317→ 9,317 totalExercise: $0.00→ Common Stock (9,317 underlying) - Exercise/Conversion
Restricted Shares
2024-04-01−6,419→ 0 totalExercise: $0.00→ Common Stock (6,419 underlying)
Footnotes (2)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance.
- [F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024.
Documents
Issuer
Core Laboratories Inc. /DE/
CIK 0001958086
Entity typeother
Related Parties
1- filerCIK 0001677384
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 5:10 PM ET
- Size
- 10.1 KB